NK1 Receptor Antagonist Blocks Angiotensin II Responses in Renin Transgenic Rat Medulla Oblongata

Hypertension

Volumn 31, Issue 1, 1998, Pages 473-479

  Diz, Debra I ^a   Westwood, Brian ^a   Bosch, Susan M ^a   Ganten, Detlev ^a   Ferrario, Carlos ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; ANGIOTENSIN; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P; SUBSTANCE P ANTAGONIST; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BIPHENYL DERIVATIVE; DRUG DERIVATIVE; RENIN; SUBSTANCE P, LEU(11),CH2NH (10 11); SUBSTANCE P, LEU(11),CH2NH-(10-11)-;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BLOOD PRESSURE REGULATION; BRADYCARDIA; BRAIN SLICE; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; HYPOTENSION; MALE; MEDULLA OBLONGATA; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; BODY WEIGHT; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IN VITRO STUDY; METABOLISM; PERFUSION; PHYSIOLOGY; SOLITARY TRACT NUCLEUS; SPRAGUE DAWLEY RAT; SYSTOLE; TRANSGENIC ANIMAL;

ANGIOTENSIN II; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIPHENYL COMPOUNDS; BLOOD PRESSURE; BODY WEIGHT; MALE; MEDULLA OBLONGATA; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; RECEPTORS, NEUROKININ-1; RENIN; SOLITARY NUCLEUS; SUBSTANCE P; SYSTOLE;

EID: 0031612147     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.473     Document Type: Article

References (48)

1. Helke CJ, O'Donohue TL, Jacobowitz DM. Substance P as a baro- and chemoreceptor afferent neurotransmitter: immunocytochemical and neurochemical evidence in the rat. Peptides. 1980;1:1-9.
2. Helke CJ. Neuroanatomical localization of substance P: implications for central cardiovascular control. Peptides. 1982;3:479-483.
3. Diz DI, Barnes KL, Ferrario CM. Contribution of the vagus nerve to angiotensin II binding in the canine medulla. Brain Res Bull. 1986;17:497-505.
4. Lewis SJ, Allen AM, Verberne AJM, Figdor R, Jarrett B, Mendelsohn FAO. Angiotensin II receptor binding in the rat nucleus tractus solitarii is reduced after unilateral nodose ganglionectomy and vagotomy. Eur J Pharmacol. 1986;125:305-307.
5. Healy DP, Rettig R, Nguyen T, Printz MP. Autoradiographic evidence that angiotensin II receptors are associated with vagal afferents and efferents within the solitary-vagal area of the rat brainstem. J Hypertens. 1986;4(Suppl 6):S462-S464.
6. Diz DI, Block CH, Barnes KL, Ferrario CM. Correlation between angiotensin II binding sites and substance P in the canine brain stem. J Hypertens. 1986;4(Suppl 6):S468-S471.
7. Szigethy EM, Barnes KL, Diz DI. Light microscopic localization of angiotensin II binding sites in canine medulla using high resolution autoradiography. Brain Res Bull. 1992;29:813-819.
8. Barnes KL, Diz DI, Ferrario CM. Functional interactions between angiotensin II and substance P in the dorsal medulla. Hypertension. 1991;17:1121-1126.
9. Diz DI, Pirro N. Differential actions of angiotensin II and angiotensin-(1-7) on transmitter release. Hypertension. 1992;19(Suppl II):II-41-II-48.
10. Diz DI, Falgui B, Bosch SM, Westwood BM, Kent J, Ganten D, Ferrario CM. Hypothalamic substance P release: attenuated angiotensin responses in mRen2(27) transgenic rats. Hypertension. 1997;29:510-513.
11. Diz DI, Barnes KL, Ferrario CM. Hypotensive actions of microinjections of angiotensin II into the dorsal motor nucleus of the vagus. J Hypertens. 1984;2:53-56.
12. Nagashima A, Takano Y, Tateishi K, Matsuoka Y, Hamaoka T, Kamiya H. Cardiovascular roles of tachykinin peptides in the nucleus tractus solitarii of rats. Brain Res. 1989;487:392-396.
13. Campagnole-Santos MJ, Diz DI, Santos RAS, Khosla MC, Brosnihan KB, Ferrario CM. Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. Am J Physiol. 1989;257:H324-H329.
14. Diz DI, Fantz DL, Benter IF, Bosch SM. Acute depressor actions of angiotensin II in the nucleus of the solitary tract are mediated by substance P. Am J Physiol. 1997;273:R28-R34.
15. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344:541-544.
16. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 1994;15:919-926.
17. Moriguchi A, Ferrario CM, Brosnihan KB, Ganten D, Morris M. Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene. Am J Physiol. 1994;267:R786-R791.
18. Tallant EA, Ganten D, Ferrario CM. Attenuated responses to angiotensin II in vascular smooth muscle cells from transgenic (mREN2) 27 rats. Am J Hypertens. 1994;7:1359. Abstract.
19. Weiss RB, Ganten D, Ferrario CM, Tallant EA. Reduced response to Ang II in astrocytes isolated from neonatal brain of (mREN2)27 transgenic rats. Hypertension. 1995;25:1410. Abstract.
20. 1) receptor. Science. 1991;251:435-437.
21. Saigo A, Takano Y, Saito R, Nakayama Y, Honda K, Kamiya H. Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor. Regul Pept. 1993;46:293-296.
22. Li P, Morris M, Diz DI, Ferrario CM, Ganten D, Callahan MF. Role of paraventricular angiotensin AT-1 receptors in salt sensitive hypertension in mREN-2 transgenic rats. Am J Physiol. 1996;270:R1178-R1181.
23. Campagnole-Santos MJ, Diz DI, Ferrario CM. Actions of angiotensin peptides after partial denervation of the solitary tract nucleus. Hypertension. 1990;15:(Suppl. I):I-34-I-39.
24. Fow JE, Averill BD, Barnes KL. Mechanisms of angiotensin-induced hypotension and bradycardia in the medial solitary tract nucleus. Am J Physiol. 1994;267:H259-H266.
25. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 2nd ed. Orlando, Fla: Academic Press; 1986:71-74.
26. Veniant M, Whitworth CE, Menard J, Sharp MGF, Gonzales M-F, Bruneval P, Mullins JJ. Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats. Am J Hypertens. 1995;8:1167-1176.
27. Chretien L, Guillemette G, Regoli D. Non-peptide angiotensin receptor antagonists bind to tachykinin NK3 receptors of rat and guinea pig brain. Eur J Pharmacol. 1994;256:73-78.
28. Picard P, Chretien L, Couture R. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat. Br J Pharmacol. 1995;114:1563-1570.
29. Maggi CA, Meli A. Suitability of urethane anesthesia for physiopharmacological investigations in various systems. 2. Cardiovascular system. Experientia. 1986;42:292-297.
30. Qian J, Coy DH, Jiang N, Gardner JD, Jensen RT. Reduced peptide bond pseudopeptide analogues of substance P: a new class of substance P receptor antagonists with enhanced specificity. J Biol Chem. 1989;264:16667-16671.
31. Diz DI, Barnes KL, Ferrario CM. Functional characteristics of neuropeptides in the dorsal medulla oblongata and vagus nerve. Fed Proc. 1987;46:30-35.
32. Barnes KL, Knowles WD, Ferrario CM. Neuronal responses to angiotensin II in the in vitro slice from the canine medulla. Hypertension. 1988;11:680-684.
33. Qu L, McQueeney AJ, Barnes KL. Presynaptic or postsynaptic location of receptors for angiotensin II and substance P in the medial solitary tract nucleus. J Neurophysiol. 1996;75:2220-2228.
34. Helke CJ, Krause JE, Mantyh PW, Couture R, Bannon MJ. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. FASEB J. 1990;4:1606-1615.
35. Chan JY, Barnes CD, Chan SH. Tonic enhancement of the sensitivity of baroreceptor reflex response by endogenous substance P in the rat. Regul Pepts. 1990;29:199-213.
36. Campagnole-Santos MJ, Diz DI, Ferrario CM. Baroreflex modulation by angiotensin II at the nucleus tractus solitarii. Hypertension. 1988;11(Suppl I):I-167-I-171.
37. Casto R, Phillips MI. Angiotensin II attenuates the baroreflexes at nucleus tractus solitarius of rats. Am J Physiol. 1986;250:R193-R198.
38. Hill JM, Pickar JG, Kaufman MP. Blockade of non-NMDA receptors attenuates reflex pressor response to static contraction. Am J Physiol. 1994;266:H1769-H1776.
39. Gurusinghe CJ, Bell C. Substance P immunoreactivity in the superior cervical ganglia of normotensive and genetically hypertensive rats. J Autonom Nerv Sys. 1989;27:249-256.
40. Nakamura K, Hayashi T. Alterations of brainstem and peripheral metenkephalin and substance P levels in spontaneously hypertensive rats. Clin Exp Theory Pract. 1984;A6:1833-1836.
41. Shigematsu K, Niwa M, Saavedra JM. Increased density of substance P binding sites in specific brainstem nuclei of spontaneously hypertensive rats. Brain Res. 1986;370:383-387.
42. Herrera-Marschitz M, Terenius L, Sakurada T, Reid MS. Ungerstedt U. The substance P(1-7) fragment is a potent modulator of substance P actions in the brain. Brain Res. 1990;521:316-320.
43. Skilling SR, Smullin DH, Larson AA. Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception. J Neurosci. 1990;10:1309-1318.
44. Yukhananov RY, Larson AA. An N-terminal fragment of substance P, substance P(1-7), down-regulates neurokinin-1 binding in the mouse spinal cord. Neurosci Lett. 1994;178:163-166.
45. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counter-regulatory actions of angiotensin-(1-7). Hypertension. 1997;30:535-541.
46. Diz DI, Bosch SM, Moriguchi A, Ganten D, Ferrario CM. Converting enzyme inhibition lowers angiotensin II receptor density in medulla of transgenic (mREN2)27 rats. J Hypertens. 1994;12:S71. Abstract.
47. Nickenig G, Laufs U, Schnabel P, Knorr A, Bohm MP Bohm M. Down-regulation of aortic and cardiac AT 1 receptor gene expression in transgenic (mRen-2) 27 rats. Br J Pharmacol. 1997;121:134-140.
48. Bacal K, Kunze DL. Dual effects of angiotensin II on calcium currents in neonatal rat nodose neurons. J Neurosci. 1994;14:7159-7167.